Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia

Author:

Jung Jae Hung12,McCutcheon Karen Ann3,Borofsky Michael4,Young Shamar5,Golzarian Jafar6,Reddy Balaji7,Shin Tae Young8,Kim Myung Ha9,Narayan Vikram4,Dahm Philipp410

Affiliation:

1. Department of Urology; Yonsei University Wonju College of Medicine; Wonju Korea, South

2. Center of Evidence Based Medicine, Institute of Convergence Science; Yonsei University; Seoul Korea, South

3. School of Nursing and Midwifery; Queen's University Belfast; Belfast UK

4. Department of Urology; University of Minnesota; Minneapolis Minnesota USA

5. Department of Radiology, Division of Interventional Radiology; University of Minnesota; Minneapolis Minnesota USA

6. Division of Interventional Radiology and Vascular Imaging; University of Minnesota; Minneapolis Minnesota USA

7. Department of Urology; Massachusetts General Hospital; Boston Massachusetts USA

8. Department of Urology; Ewha Womans University; Seoul Korea, South

9. Yonsei Wonju Medical Library; Yonsei University Wonju College of Medicine; Wonju Korea, South

10. Urology Section; Minneapolis VA Health Care System; Minneapolis Minnesota USA

Publisher

Wiley

Subject

Pharmacology (medical)

Reference110 articles.

1. Prostatic artery embolization vs conventional TUR-P in the treatment of benign prostatic hyperplasia: first results of a prospective, randomized non-inferiority trial;Abt;European Urology Supplement,2016

2. Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial;Abt;BMJ,2018

3. Prostatic artery embolization versus conventional TUR-P in the treatment of benign prostatic hyperplasia: protocol for a prospective randomized non-inferiority trial;Abt;BMC Urology,2014

4. Prostatic artery embolization vs. conventional transurethral prostatectomy in the treatment of benign prostatic hyperplasia https://clinicaltrials.gov/ct2/show/NCT02054013

5. Database for the assessment of efficacy and safety of BPH treatment https://clinicaltrials.gov/show/NCT03521648

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3